Thomas K. Equels, CFO, President, Secretary, Vice Chairman at HEMISPHERX BIOPHARMA INC (HEB), bought 79,104 shares at $0.18 ($14K) on 2015-08-13, disclosed to the SEC on 2015-08-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.18 | 12,600 | $2K | 15.9% |
| 2 | $0.18 | 16,504 | $3K | 20.9% |
| 3 | $0.18 | 50,000 | $9K | 63.2% |
| Total | $0.18 avg | 79,104 | $14K | 100% |
| Filing → |
| AIM | BUY | 2020-12-17 | $25K | — | Filing → |
| AIM | BUY | 2020-09-03 | $25K | — | Filing → |
| AIM | BUY | 2020-08-21 | $25K | — | Filing → |